FDA and CTTI Launch Patient Forum to Boost Engagement in Drug Development

International Pharmaceutical Regulatory Monitor
A A
The Patient Engagement Collaborative is gearing up for a launch in early 2018. The new, external panel is being built by the FDA and the Clinical Trials Transformation Initiative (CTTI), a public-private partnership between the FDA and Duke University.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor